Patients
Physicians
Sponsors
Oncologists
About Us
News
ENG
Last updated 21 days ago
Share
Mechanistic Study of the Effect of Itepekimab on Airway Inflammation in Patients With COPD
60 patients around the world
Available in
Brazil, United States
Sanofi
1
Research sites
60
Patients around the world
This study is for people with
Chronic obstructive pulmonary disease
Copd
Requirements for the patient
To 70 Years
All Gender
Medical requirements
Inclusion criteria
Exclusion criteria
Sites
Hospital São Lucas da Pontifícia Universidade Católica do Rio Grande do Sul
Recruiting
Consult
View site
Av. Ipiranga, 6690 - 4º andar - Partenon, Porto Alegre - RS, 90610-001, Brazil
View site
Consult
See details
Contact us
Contact us
Study
AERIFY-3
Sponsor
Sanofi
Conditions
Copd
Requirements
To 70 Years
All Gender
Unique study ID
clinicaltrials.gov
NCT05326412
About us
Our mission
Our team
Partners
FAQs
Medical news
Latest news
Studies
Interviews
Testimonials
Products
UEPM Onco
UEPM Physicians
Links
Downloads
English
Terms and Conditions
Privacy Policy
Change your consent
English
Terms and Conditions
Privacy Policy
Change your consent
English
Terms and Conditions
Privacy Policy
Change your consent